Diaphragmatic palsy with brachial plexus block
Conditions
Interventions
Test group:0.375% ropivacaine for brachial plexus nerve block in the intercostal lock space
Control group:Supraclavicular brachial plexus nerve block with 0.375% ropivacaine
Sponsors
Department of Anesthesiology, Southern Hospital of Southern Medical University, Guangzhou, Guangdong, China
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients undergoing elective forearm or hand surgery, regardless of gender, ASA ?~?, age 18~65 years, BMI 18~28kg/m2, voluntarily participated in this trial and signed the informed consent form
Exclusion criteria
Exclusion criteria: History of allergy to local anesthetics, nerve damage and sensory abnormalities in the affected limb, coagulation system abnormalities, puncture site breakdown or infection, mental, speech and hearing impairment, previous history of phrenic nerve injury, inability to cooperate with calm breathing and deep breathing exercises, participation in clinical trials within the last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Unilateral diaphragmatic mobility 30 min after drug injection;Diaphragmatic mobility before block; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensory and exercise onset time;Sensory and motor recovery time;Adverse events occurring;operation time; | — |
Countries
China
Contacts
Public ContactFang Haihong
Department of Anesthesiology, Southern Hospital of Southern Medical University, Guangzhou, Guangdong, China
Outcome results
None listed